Bahamondez, Alvarez & Zegers Ltda. advises Trigemina Inc. in its stock swap and in the investment made by Venture Capital Fund Aurus Bio
Bahamondez, Alvarez & Zegers have assisted Trigemina Inc in its incorporation in Chile, its stock swap with Trigemina Chile and in the investment of Series A-1 Preferred Stock made by Venture Capital Fund Aurus Bio.
Trigemina Inc., a Mountain View, California, based pharmaceutical company, focuses on research to develop medication to cure Chronic Daily Headache.
The multistep transaction included a stock swap to allow Trigemina Chile SpA to become the holding company of Trigemina Inc, and saw venture capital fund Aurus Bios invest an undisclosed sum in the new company.
This deal is a landmark for the VC industry in LatAm, because is one of the first cases when a Silicon Valley based company has come to LatAm to raise money, with a complex corporate structure to allow sophisticated foreign investors to be comfortable having a holding company in Chile.
The Bahamondez, Alvarez & Zegers team included partners Matías Zegers and Rodrigo Alvarez and associates Cristóbal Silva, Gonzalo Rivera and Cristóbal Smythe.